Ad is loading...
MENU
BCTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BriaCell Therapeutics (BCTX) Ownership - Who owns BriaCell Therapeutics?
Profile
Industry
N/A
Address
235 - 15th Street
Phone
+1 604 921-1810
Employees
12
Web
https://www.briacell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
28.22M
P/E Ratio
N/A
Total Cash
935.69K
Projected Growth
N/A
Total Debt
26.96K
Revenue
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
0.03
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BCTX
Capitalization
28.2M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
936K
Total Cash/Share
0.03
Total Debt
27K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-5.97M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.37
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
69.6M
Current Ratio
0.82
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-32.28M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-33.38
Shares Held By Institutions
421K
Shares Outstanding - Current
36.2M
Total Liabilities
12.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-86.513
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
235 - 15th Street
Phone
+1 604 921-1810
Employees
12
Web
https://www.briacell.com